Ceapro Inc. (TSXV: CZO), a company engaged in the
development and commercialization of natural products for personal care,
cosmetic, human and animal health industries using technology, natural and
renewable resources, recorded over 30% gains during each of the past two
consecutive trading sessions with a significant number of shares exchanging
hands. CZO was among the top performers in the Canadian healthcare sector after gaining 33.3% and closed at C$0.40 Monday, while recording significant trading volumes of 323,660 shares. Recently, the company has announced its financial results for Q3’14 ended September 30, 2014, where it reported total sales of C$2,445,000, an increase of 22% against Q3’13 sales, making this as highest quarterly revenue to date. CZO’s net profit stood at C$690,000 for Q3’14 versus C$123,000 in Q3’13. During the past 5-trading sessions, CZO gained 77.8% with daily average trading volumes of 359,394 shares, while the stock accumulated 56.9% gain during the past one month with daily average trading volumes of 76,126 shares. The stock is up 344.4% year-to-date.
Company Description:
Ceapro Inc. (TSXV: CZO) develops and utilizes core technologies to supply materials and compounds to the life sciences and personal care and cosmetics industries. The company discovers, develops, and produces natural health products derived from oats and other grains. Ceapro markets its products under the Ostar brand name.
1-Year Stock Chart:
Source: Bloomberg
